Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oncology Institute, Inc. ( (TOI) ) has shared an announcement.
On February 26, 2025, The Oncology Institute, Inc. announced an amendment to its facility agreement with Deerfield Management, removing certain financial restrictions and paying down $20 million of convertible notes. This move strengthens TOI’s financial position, enabling it to focus on growth initiatives, including new capitation agreements covering 80,000 lives in California, Nevada, and Florida, and expanding its value-based agreements in Florida to over 200,000 lives.
More about Oncology Institute, Inc.
The Oncology Institute, Inc. (TOI) is a leading value-based community oncology group in the United States, offering specialized cancer care through clinical trials, transfusions, and other advanced services. Founded in 2007, TOI serves over 1.8 million patients with more than 120 clinicians across 70 locations.
YTD Price Performance: 175.17%
Average Trading Volume: 1,292,863
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $60.36M
Find detailed analytics on TOI stock on TipRanks’ Stock Analysis page.